# Usefulness of Selegiline as an Aid to Quit Smoking - 1

> **NCT00129311** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 101 (actual)

## Conditions studied

- Tobacco Use Cessation

## Interventions

- **DRUG:** Selegiline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00129311
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2015-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00129311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00129311, "Usefulness of Selegiline as an Aid to Quit Smoking - 1". Retrieved via MORVS 2026-10-30 from https://api.morvs.ai/clinical/NCT00129311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*